Podcasts about clinical chief

In this episode, Dr. Azadeh Shirazi sits down with Dr. Joubin Gabbay, Clinical Chief of Plastic Surgery at Cedars-Sinai in Beverly Hills, to explore the intersection of longevity and regenerative medicine in Aesthetics. They dive into the future of facial rejuvenation with expert insights on human-derived tissue injections like AlloCclae vs traditional fillers, NanoFat, Sculptra, facial implants, buccal fat removal, and more. If you're curious about what's next in aesthetic medicine—from collagen stimulation to regenerative facial rejuvenation—this one's for you.   Timeline of what was discussed: 00:00 Introduction 02:09 Human-Derived Tissue Injection vs Traditional Fillers 04:28 Renuva: a substitute for fat grafting? 05:57 Human-Derived Fat Injection vs Natural Fat  07:49 Can you use Renuva on the face?  08:47 Good candidates for Renuva & AlloCclae 10:11 Does AlloCclae behave similarly to natural fat? 11:36 Dr. Joubin's opinion on Fillers  13:30 Nanofat Explained 15:54 Fat for Breast Augmentation 17:34 Dr. Joubin's Favorite Treatments  18:58  Buccal Fat Reduction 20:13 Facial Implants 21:37 CaHa vs Sculptra   ______________________________________________________________ Submit your questions for the podcast to Dr. Azi on Instagram @morethanaprettyfacepodcast, @skinbydrazi, on YouTube, and TikTok @skinbydrazi. Email morethanaprettyfacepodcast@gmail.com. Shop skincare at https://azimdskincare.com and learn more about the practice at https://www.lajollalaserderm.com/ The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice. © Azadeh Shirazi, MD FAAD.  

In this episode, Ayesha spoke with John Yu, MD, CEO of Kairos Pharma, a company advancing therapies to overcome challenges in cancer drug resistance and immune suppression. Kairos is developing therapeutics that reverse cancer drug resistance in cancers such as prostate and lung cancer. The company's lead candidate, ENV105, is an antibody targeting CD105, which is implicated in cancer cell resistance to various treatments. By inhibiting CD105, ENV105 seeks to restore the effectiveness of standard therapies across multiple cancer types. Dr. Yu is also Professor and Clinical Chief of Neurosurgery, Director of the Brain Tumor Center at Cedars Sinai Medical Center. He has developed numerous immunotherapies and nanotechnologies from his National Institutes of Health (NIH) funded laboratory. This includes eight new investigational drugs with the US Food and Drug Administration. Dr. Yu has also led numerous clinical trials. Dr. Yu served in leadership roles at several biotechs, including ImmunoCellular Therapeutics and most recently served as CEO and Chairman of AcTcell and Director of Enviro Therapeutics. Dr. Yu has an MD from Harvard Medical School and MIT, and completed an Immunology Fellowship at the Institut Pasteur, Paris. Tune into the episode, to hear more about the work Dr. Yu is leading at Kairos Pharma to address cancer drug resistance. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

The following question refers to Section 2.2 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.The question is asked by University of Colorado internal medicine resident Dr. Hirsh Elhence, answered first by University of Chicago advanced heart failure cardiologist and Co-Chair for the CardioNerds Critical Care Cardiology Series Dr. Mark Belkin, and then by expert faculty Dr. Mark Drazner.Dr. Drazner is an advanced heart failure and transplant cardiologist, Professor of Medicine, and Clinical Chief of Cardiology at UT Southwestern. He is the President of the Heart Failure Society of America.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values.  Question #35 A 50-year-old woman with a history of congestive heart failure, hypertension, type 2 diabetes mellitus, and obstructive sleep apnea presents to the outpatient clinic to follow up on her heart failure management. One year prior, echocardiogram showed an ejection fraction of 30% with an elevated BNP, for which she was started on appropriate GDMT. Repeat echocardiogram today showed an EF of 50%. Which of the following best describes her heart failure status? A HFrEF (HF with reduced EF) B HFimpEF (HF with improved EF) C HFmrEF (HF with mildly reduced EF) D HFpEF (HF with preserved EF) Answer #35 Explanation The correct answer is B – HFimpEF, or heart failure with improved ejection fraction, best describes her current heart failure status. Left ventricular ejection fraction is an important factor in classifying heart failure given differences in prognosis, response to treatment, and use in clinical trial enrollment criteria. The classification of heart failure by EF (adopted from the Universal Definition of HF): –        HFrEF (HF with reduced EF): LVEF ≤40% –        HFimpEF (HF with improved EF): previous LVEF ≤40%, a ≥10% increase from baseline LVEF, and a second measurement of LVEF >40%. –        HFmrEF (HF with mildly reduced EF): LVEF 41%–49%, andevidence of spontaneous or provokable increased LV filling pressures (e.g., elevated natriuretic peptide, noninvasive and invasive hemodynamic measurement) –        HFpEF (HF with preserved EF): LVEF ≥50%, and evidence of spontaneous or provokable increased LV filling pressures (e.g., elevated natriuretic peptide, noninvasive and invasive hemodynamic measurement) Patients with HFmrEF are usually in a dynamic state of improving from HFrEF or deteriorating towards HFrEF. Therefore, patients with HFmrEF may benefit from follow-up evaluation of systolic function and etiology of sub-normal EF. Improvements in EF are associated with better outcomes but do not indicate full myocardial recovery or normalization of LV function. Indeed, structural and functional abnormalities such as LV dilation and systolic or diastolic dysfunction often persist. Moreover, EF may remain dynamic with fluctuations in either direction depending on factors such as GDMT adherence and re-exposure to cardiotoxic agents. As such, the term heart failure with “improved EF” was deliberately chosen over “recovered EF” and “preserved EF”. Importantly, in patients with HFimpEF while on GDMT, the EF may decrease after withdrawal of GDMT. Main Takeaway

The following question refers to Sections 6.1 and 7.4 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.The question is asked by University of Colorado internal medicine resident Dr. Hirsh Elhence, answered first by University of Chicago advanced heart failure cardiologist and Co-Chair for the CardioNerds Critical Care Cardiology Series Dr. Mark Belkin, and then by expert faculty Dr. Mark Drazner.Dr. Drazner is an advanced heart failure and transplant cardiologist, Professor of Medicine, and Clinical Chief of Cardiology at UT Southwestern. He is the President of the Heart Failure Society of America.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. /*! elementor - v3.23.0 - 25-07-2024 */ .elementor-toggle{text-align:start}.elementor-toggle .elementor-tab-title{font-weight:700;line-height:1;margin:0;padding:15px;border-bottom:1px solid #d5d8dc;cursor:pointer;outline:none}.elementor-toggle .elementor-tab-title .elementor-toggle-icon{display:inline-block;width:1em}.elementor-toggle .elementor-tab-title .elementor-toggle-icon svg{margin-inline-start:-5px;width:1em;height:1em}.elementor-toggle .elementor-tab-title .elementor-toggle-icon.elementor-toggle-icon-right{float:right;text-align:right}.elementor-toggle .elementor-tab-title .elementor-toggle-icon.elementor-toggle-icon-left{float:left;text-align:left}.elementor-toggle .elementor-tab-title .elementor-toggle-icon .elementor-toggle-icon-closed{display:block}.elementor-toggle .elementor-tab-title .elementor-toggle-icon .elementor-toggle-icon-opened{display:none}.elementor-toggle .elementor-tab-title.elementor-active{border-bottom:none}.elementor-toggle .elementor-tab-title.elementor-active .elementor-toggle-icon-closed{display:none}.elementor-toggle .elementor-tab-title.elementor-active .elementor-toggle-icon-opened{display:block}.elementor-toggle .elementor-tab-content{padding:15px;border-bottom:1px solid #d5d8dc;display:none}@media (max-width:767px){.elementor-toggle .elementor-tab-title{padding:12px}.elementor-toggle .elementor-tab-content{padding:12px 10px}}.e-con-inner>.elementor-widget-toggle,.e-con>.elementor-widget-toggle{width:var(--container-widget-width);--flex-grow:var(--container-widget-flex-grow)} Question #34 Question StemA 72-year-old woman with a history of hypertension, type 2 diabetes mellitus, and a recent myocardial infarction is seen in your clinic. Two months previously, she was hospitalized with a myocardial infarction and underwent successful revascularization of the left anterior descending artery with a drug-eluting stent. Following her myocardial infarction, an echocardiogram revealed an ejection fraction of 17%, and she was discharged on metoprolol succinate, lisinopril, spironolactone, and dapagliflozin with escalation to maximal tolerated doses over subsequent visits. A repeat echocardiogram performed today in your clinic reveals an ejection fraction of 26%. An electrocardiogram reveals normal sinus rhythm with a narrow QRS at a heart rate of 65 beats per minute. She is grateful for her cardiac rehabilitation program and reports no ongoing symptoms. Which of the following devices is indicated for placement at this time?Answer choicesAImplantable loop recorderBICDCCRT-DDCRT-P Answer #34 Explanation The correct answer is B.

Happy summer! Fr. Nathan is taking a few weeks off from recording The Joyful Friar Podcast. During this time, we will be replaying the most-watched episodes!Enjoy this encore episode where Fr. Nathan discusses Dr. Bruce Greyson's research on near-death experiences.Dr. Bruce Greyson is the Chester Carlson Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia.  He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry. Dr. Greyson has consulted with the National Institutes of Health and addressed symposia on consciousness at the United Nations and at the Dalai Lama's compound in Dharamsala, India. He has earned awards for his medical research and was elected a Distinguished Life Fellow of the American Psychiatric Association, the highest honor bestowed by that organization.Dr. Greyson's interest in near-death experiences began just a few months after graduating from medical school, when he treated an unconscious patient in the emergency room who stunned him the next morning with an account of leaving her body. That event challenged his beliefs about the mind and the brain, and ultimately led him on a journey to study near-death experiences scientifically, leading to more than a hundred publications in medical journals. He co-founded the International Association for Near-Death Studies (IANDS), an organization to support and promote research into these experiences, and for 27 years edited the Journal of Near-Death Studies, the only scholarly journal dedicated to near-death research. Through his research, he has discovered common and universal themes in near-death experiences that go beyond neurophysiological or cultural interpretations, as well as patterns of consistent aftereffects on individuals' attitudes, beliefs, values, and personalities.Dr. Greyson is the author of "After: A Doctor Explores What Near-Death Experiences Reveal About Life and Beyond." The book challenges our everyday ideas about our minds and our brains and offers key insights on how we can begin to live a more meaningful and fulfilling life.https://www.brucegreyson.comClick this link and let us know what you love about The Joyful Friar Podcast! ​Connect with Father Nathan Castle, O.P.

Sue Yom, our Editor-in-Chief, co-hosts with Dr. Salma Jabbour, Deputy Editor at the Red Journal and Professor, Vice Chair of Clinical Research and Faculty Development, and Clinical Chief of the Department of Radiation Oncology at Rutgers University. Guests include Drs. Amar Kishan, Professor, Vice Chair of Clinical and Translational Research, and Chief of the Genitourinary Oncology Service, and Minsong Cao, Professor, Vice Chair of Academic Mission Development, and Director of the Medical Physics Residency Training Program, who were supervising authors on a new study published this month, Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial. We also welcome Dr. Lauren Henke, Associate Professor of Radiation Oncology and Director of Gastrointestinal Radiation Oncology at the University Hospitals, Case Western Reserve University, who authored an editorial this month entitled Undoing the Layers: Magnetic Resonance Imaging/Advanced Image Guidance and Adaptive Radiation Therapy.

Fr. Nathan discusses Dr. Bruce Greyson's research work on near-death experiences. Dr. Bruce Greyson is the Chester Carlson Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia.  He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry. Dr. Greyson has consulted with the National Institutes of Health and addressed symposia on consciousness at the United Nations and at the Dalai Lama's compound in Dharamsala, India. He has earned awards for his medical research and was elected a Distinguished Life Fellow of the American Psychiatric Association, the highest honor bestowed by that organization.Dr. Greyson's interest in near-death experiences began just a few months after graduating from medical school, when he treated an unconscious patient in the emergency room who stunned him the next morning with an account of leaving her body. That event challenged his beliefs about the mind and the brain, and ultimately led him on a journey to study near-death experiences scientifically, leading to more than a hundred publications in medical journals. He co-founded the International Association for Near-Death Studies (IANDS), an organization to support and promote research into these experiences, and for 27 years edited the Journal of Near-Death Studies, the only scholarly journal dedicated to near-death research. Through his research, he has discovered common and universal themes in near-death experiences that go beyond neurophysiological or cultural interpretations, as well as patterns of consistent aftereffects on individuals' attitudes, beliefs, values, and personalities.Dr. Greyson is the author of After: A Doctor Explores What Near-Death Experiences Reveal About Life and Beyond. The book challenges our everyday ideas about our minds and our brains and offers key insights on how we can begin to live a more meaningful and fulfilling life.https://www.brucegreyson.com​Connect with Father Nathan Castle, O.P.

Earlier this week, the provincial government and provincial health authority announced plans for a suite of services and supports for seniors. Dr. Susan Mercer is the Clinical Chief of Older Adult Care with Newfoundland and Labrador Health Services. She joined us to talk about the new plan.

Thank you for joining us for another episode of the Low Carb MD Podcast. Dr. Steven Palter is the Founder and Medical and Scientific Director of Gold Coast IVF in Woodbury, NY. He has dedicated his career to making the dreams of infertile couples come true and is internationally recognized as a leader in the field of fertility treatment. Previously a member of the Yale faculty, he was Clinical Chief of Reproductive Endocrinology and the Founder and Director of many additional programs including the Advanced Endoscopy Fellowship and the Yale Oncofertility Program. He has also served on the Board of Directors of the leading minimally invasive surgery society in the world, the AAGL. In this conversation, Drs. Tro and Steven talk about the holistic approach to infertility care, what it means to be an OBGYN and a reproductive endocrinologist, the degree to which nutrition and metabolic health are factors in infertility, why the medical system is geared toward volume rather than excellence and success, how to determine whether or not you should find a new doctor, the usage of low-carb diets as treatment for PCOS, and principles of successful patient empowerment. For more information, please see the links below. Thank you for listening! Links: Dr. Steven Palter: Gold Coast IVF Instagram YouTube Get Pregnant Now (book) Dr. Brian Lenzkes: Website Twitter Dr. Tro Kalayjian: Website Twitter Instagram Doctor Tro App Join a growing community of individuals who are improving their metabolic health; together. Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more. Apple Google Learn more

Join Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, and Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute, as they delve into the depths of radiation therapy in cancer care. Together they'll unravel the intricacies of this vital treatment option, covering its mechanisms, innovations, and the pivotal role it plays in the journey towards effective oncological treatment for patients. For more information, please visit: www.CarisLifeSciences.com

Dr. Bruce Greyson is Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia.  He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry. Dr. Greyson has consulted with the National Institutes of Health and addressed symposia on consciousness at the United Nations and at the Dalai Lama's compound in Dharamsala, India. He has earned awards for his medical research and was elected a Distinguished Life Fellow of the American Psychiatric Association, the highest honor bestowed by that organization.Dr. Greyson's interest in near-death experiences began just a few months after graduating from medical school, when he treated an unconscious patient in the emergency room who stunned him the next morning with an account of leaving her body. That event challenged his beliefs about the mind and the brain, and ultimately led him on a journey to study near-death experiences scientifically, leading to more than a hundred publications in medical journals. He co-founded the International Association for Near-Death Studies (IANDS), an organization to support and promote research into these experiences, and for 27 years edited the Journal of Near-Death Studies, the only scholarly journal dedicated to near-death research. Dr. Greyson is the author of After: A Doctor Explores What Near-Death Experiences Reveal About Life and Beyond.

In this episode we speak with Dr. Silvio Inzucchi about Type 2 diabetes and medications such as Ozempic and Wegovy that are now being used for weight loss. Dr. Inzucchi is a Professor of Medicine at the Yale University School of Medicine, where he also serves as the Clinical Chief of the Section of Endocrinology, the Medical Director of the Yale Diabetes Center, and the Program Director of the Endocrinology & Metabolism Fellowship. We start the conversation with an overview of Type 2 diabetes, shedding light on its diagnosis, factors leading to it, and the differences between Type 1 and Type 2. Our discussion then shifts to medications pivotal in its management, such as metformin and the increasingly recognized Ozempic, which is also being explored for weight loss. Dr. Inzucchi helps demystify the varying medications, offering insights on their applications, side effects, and the role they play in weight management.  Host: Brent Franson, Founder & CEO, Most Days Guest: Dr. Silvio Inzucchi Music: Patrick Lee Production: Patrick Godino

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute. Together they discuss a plenary presentation that was given at ASCO 2023 on rectal cancer titled, the PROSPECT (Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and TME) trial. The PROSPECT trial attempts to challenge the current treatment paradigm by individualizing treatment through the use of radiotherapy selectively rather than reflexively. This is a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for the treatment of locally advanced rectal cancer (LARC). For more information, please visit: www.CarisLifeSciences.com/POA-Intro/

The following question refers to Sections 6.1 and 7.3 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by Keck School of Medicine USC medical student & former CardioNerds Intern Hirsh Elhence, answered first by Greater Baltimore Medical Center medicine resident and CardioNerds Academy Fellow Dr. Alaa Diab, and then by expert faculty Dr. Mark Drazner. Dr. Drazner is an advanced heart failure and transplant cardiologist, Professor of Medicine, and Clinical Chief of Cardiology at UT Southwestern. He is the past President of the Heart Failure Society of America.  The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. Question #25 A 50-year-old man with a history of type 2 diabetes mellitus, persistent atrial fibrillation, coronary artery disease with prior remote percutaneous coronary intervention, and ischemic cardiomyopathy with HFrEF (LVEF 38%) presents to your outpatient clinic. He denies dyspnea on exertion, orthopnea, bendopnea, paroxysmal nocturnal dyspnea, or peripheral edema. His heart rate is irregularly irregular at 112 beats per minute and blood pressure is 112/67 mmHg. Routine laboratory studies reveal a hemoglobin A1c of 7.7%. Which of the following medications should not be used to control this patient's comorbidities? A Metoprolol succinate B Verapamil C Dapagliflozin D Pioglitizone E Both B and D Answer #25 Explanation The correct answer is E – both verapamil and pioglitazone should be avoided here. Both verapamil and pioglitizone are associated with harm in patients with LVEF < 50% (Class 3: Harm). Verapamil and diltiazem are non-dihydropyridine calcium channel blockers. These medications can cause negative inotropic effects through inhibition of calcium influx and may be harmful in this patient population. Pioglitizone belongs to a class of diabetic medications known as the thiazolidinediones. This class of medications may increase the risk of fluid retention, heart failure, and hospitalization in patients with LVEF of less than 50%. Metoprolol succinate, and other evidence-based beta blockers, have a Class 1 recommendation for patients with reduced ejection fraction ≤ 40% to prevent symptomatic heart failure and reduce mortality. It may additionally help with rate control in this patient with atrial fibrillation and rapid ventricular response. SGLT2 inhibitors including dapagliflozin have a Class I recommendation for patients with symptomatic chronic HFrEF to reduce hospitalization for HF and cardiovascular mortality, irrespective of the presence of type 2 diabetes (Class 1, LOE A). They also have a Class I recommendation in patients with type 2 diabetes and either established CVD or at high cardiovascular risk to prevent hospitalization for HF (Class 1, LOE A). Our patient has asymptomatic, or pre-HF (Stage B) heart failure with poorly controlled diabetes, and so use of an SGLT2 inhibitor would be appropriate. Main Takeaway Non-dihydropyridine calcium channel blockers and thiozolidinediones both have Class 3 recommendations for harm in patients with reduced LV systolic dysfunction. Guideline Loc. Section 6.1 and 7.3   Decipher the Guidelines: 2022 Heart Failure Guidelines PageCardioNerds Episode PageCardioNerds Academ...

Dr. Zeev Neuwirth, Clinical Chief of Care Transformation for Atrium Health, returns to the Fixing Healthcare podcast for a tell-all talk about leadership in healthcare: the good, the bad and ... The post FHC #93: Zeev Neuwirth on the future of healthcare appeared first on Fixing Healthcare.

Osteoarthritis (OA) is the most common form of arthritis. There are currently no effective disease-modifying treatments available to slow or reverse the progression of OA. Drugs such as metformin, which is commonly used to treat type 2 diabetes are generally safe and low cost. Research has been shown that metformin has anti-inflammatory and pro-weight loss effects, suggesting that the use of metformin may be useful in the treatment or prevention of OA. Dr Matthew Baker joins us on this week's episode of Joint Action to discuss this important topic. Dr. Matthew Baker is the Clinical Chief in the Division of Immunology and Rheumatology at Stanford University. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker has established a clinical research program that is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials with a focus on sarcoidosis, IgG4-related disease, and rheumatoid arthritis. In addition, he is the Co-Director of the Stanford Multidisciplinary Sarcoidosis Program and collaborates with other team members to advance sarcoidosis clinical care and research.RESOURCESDevelopment of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a SulfonylureaIncreased risk of osteoarthritis in patients with atopic diseaseCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

The following question refers to Section 6.1 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by Keck School of Medicine USC medical student & CardioNerds Intern Hirsh Elhence, answered first by Mount Sinai Hospital cardiology fellow and CardioNerds FIT Trialist Dr. Jason Feinman, and then by expert faculty Dr. Mark Drazner. Dr. Drazner is an advanced heart failure and transplant cardiologist, Professor of Medicine, and Clinical Chief of Cardiology at UT Southwestern. He is the President of the Heart Failure Society of America. The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. Question #2 A 67-year-old man with a past medical history of type 2 diabetes mellitus, hypertension, and active tobacco smoking presents to the emergency room with substernal chest pain for the past 5 hours. An electrocardiogram reveals ST segment elevations in the anterior precordial leads and he is transferred emergently to the catheterization laboratory. Coronary angiography reveals 100% occlusion of the proximal left anterior descending artery, and he is successfully treated with a drug eluting stent resulting in TIMI 3 coronary flow. Following his procedure, a transthoracic echocardiogram is performed which reveals a left ventricular ejection fraction of 35% with a hypokinetic anterior wall. Which of the following medications would be the best choice to prevent the incidence of heart failure and reduce mortality? A Lisinopril B Diltiazem C Carvedilol D Sacubitril-valsartan E Both A and C Answer #2 The correct answer is E – both lisinopril and carvedilol are appropriate to reduce the incidence of heart failure and mortality. Evidence-based beta-blockers and ACE inhibitors both have Class 1 recommendations in patients with a recent myocardial infarction and left ventricular ejection fraction ≤ 40% to reduce the incidence of heart failure and to reduce mortality. Multiple randomized controlled trials have investigated both medications in the post myocardial infarction setting and demonstrated improved ventricular remodeling as well as benefits for mortality and development of incident heart failure. At this time, there is not sufficient evidence to recommend ARNi over ACEi for patients with reduced LVEF following acute MI. The PARADISE-MI trial randomized a total of 5,661 patients with myocardial infarction complicated by a reduced LVEF, pulmonary congestion, or both to receive either sacubitril-valsartan (97-103mg twice daily) or ramipril (5mg twice daily). After a median follow up time of 22 months, there was no statistically significant difference in the primary outcome of cardiovascular death or incident heart failure. At this time, ARNi have not been included in the guidelines for this specific population. Diltiazem is a non-dihydropyridine calcium channel blocker, a family of drugs with negative inotropic effects and which may be harmful in patients with depressed LVEF (Class 3: Harm, LOE C-LD). Main Takeaway:  For patients with recent myocardial infarction and reduced left ventricular function both beta blockers and ACEi have Class 1 recommendations to reduce the incidence of heart failure and decrease mortality. Guideline Location: Section 6.1

So many of us fear death because what happens in the afterlife is unknown. However, thanks to a half-century of research from Dr. Bruce Grayon on near-death experiences (NDEs), we do have clues into what happens to consciousness after death. Listen in as James and Bruce discuss learning and insights from thousands of NDEs and how we can use them to make the most of our lives here on earth. Dr. Bruce Greyson is Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia School of Medicine. He served on the full-time medical school faculty at the University of Michigan; at the University of Connecticut, where he was Clinical Chief of Psychiatry; and at the University of Virginia, where he held the endowed Chester Carlson Professorship and was Director of the Division of Perceptual Studies. He was a co-founder and President of the International Association for Near-Death Studies, and for 26 years edited the Journal of Near-Death Studies, the only peer-reviewed academic journal devoted to near-death experiences. Dr. Greyson has published more than a hundred scholarly articles about near-death experiences in peer-reviewed medical journals and three academic books. His research for the past four decades has focused on near-death experiences and particularly their after-effects and implications. His new book. After: A Doctor Explores What Near-Death Experiences Reveal about Life and Beyond, is his first trade book bringing his scientific research to a popular audience. www.brucegreyson.com www.uvadops.org

On the heels of National Coming Out Day, BloodStream is joined by Dr. Nathan Connell, Clinical Chief of Hematology at Brigham and Women's Faulkner Hospital to discuss LGBTQ+ health issues in the bleeding disorder community. Plus, Patrick reconnects with Annelise Ellis, longtime friend and fellow person with a bleeding disorder, as she shares with us her story of how von Willebrand disease impacted her first pregnancy, labor, and delivery.   Show Notes: Subscribe: The BloodStream Podcast   Presenting Sponsor: Takeda, visit bleedingdisorders.com to learn more.   Episode and Segment Sponsors:  Genentech, open enrollment is right around the corner and Genentech has resources to support you through this process. To learn more about these resources, visit www.HemophiliaAccess.com  CSL Behring, visit HemEvolution.com to learn more about gene therapy, or ProtraitsofProgress.com for a virtual photo exhibition chronicling hemophilia's history Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook  BloodStream on Twitter 

Deputy Editor Dr. Salma Jabbour, Vice Chair of Clinical Research and Faculty Development and Clinical Chief in the Department of Radiation Oncology at the Rutgers Cancer Institute of New Jersey, hosts Dr. Matthias Guckenberger, Chairman and Professor of the Department of Radiation Oncology at the University Hospital Zurich and University of Zurich, discussing a new article from his European team, "Completeness of reporting oligometastatic disease characteristics in the literature and influence on oligometastatic disease classification using the ESTRO/EORTC nomenclature," and Dr. David Palma, Clinician Scientist II at the Ontario Institute for Cancer Research, Radiation Oncologist at the London Health Sciences Center, and Associate Professor at Western University, who was the supervising author on the 5-year update of the SABR-COMET trial, " Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) – Extended Long-Term Outcomes."

Dr. Bruce Greyson- Why Near Death Experiences Matter. ACU Sunday Series. Watch this speech at- https://youtu.be/DJ1Hq84SctI 24,880 views Jan 9, 2021 IANDSvideos 43.5K subscribers Considered the “father” of NDE research, Dr. Bruce Greyson discusses why near-death experiences matter to experiencers, science, healthcare and society-at-large.

Health authorities across the province are reviewing potential problems with the viewing of mammogram results. Wednesday afternoon. Central Health gave reasons behind what it calls 'diagnostic discrepancies.' That health authority held a media availability Wednesday to talk about the issue. Andrée Robichaud is President and Chief Executive Officer of Central Health, and Dr. Angela Pickles is Clinical Chief of Medical Imaging with Eastern Health.

Dr. Bruce Greyson is the Chester Carlson Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia.  He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry.Dr. Greyson has consulted with the National Institutes of Health and addressed symposia on consciousness at the United Nations and at the Dalai Lama's compound in Dharamsala, India. He has earned awards for his medical research and was elected a Distinguished Life Fellow of the American Psychiatric Association, the highest honor bestowed by that organization.Dr. Greyson's interest in near-death experiences began just a few months after graduating from medical school, when he treated an unconscious patient in the emergency room who stunned him the next morning with an account of leaving her body. That event challenged his beliefs about the mind and the brain, and ultimately led him on a journey to study near-death experiences scientifically, leading to more than a hundred publications in medical journals.He co-founded the International Association for Near-Death Studies (IANDS), an organization to support and promote research into these experiences, and for 27 years edited the Journal of Near-Death Studies, the only scholarly journal dedicated to near-death research. Through his research, he has discovered common and universal themes in near-death experiences that go beyond neurophysiological or cultural interpretations, as well as patterns of consistent aftereffects on individuals' attitudes, beliefs, values, and personalities.Dr. Greyson is the author of After: A Doctor Explores What Near-Death Experiences Reveal About Life and Beyond. The book challenges our everyday ideas about our minds and our brains and offers key insights on how we can begin to live a more meaningful and fulfilling life.

Dr. Bruce Greyson joins the podcast to discuss his research into Near Death Experiences, spanning over decades. Dr. Greyson is the Chester Carlson Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia.  He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry. For many of us, the question of whether or not consciousness survives bodily death is one of, if not the most important question one could ask. Dr. Greyson goes into great detail discussing captivating experiences from many patients he came into contact with, as well as the profound effects NDE's have on the experiencer's life. We can't thank Dr. Greyson enough for taking the time to share his knowledge with us. If you'd like to read more about Dr. Greyson's work, first-hand accounts and the scientific research being conducted in this area, please check out his book and website: ► After: A Doctor Explores What Near-Death Experiences Reveal About Life and Beyond ► Dr. Bruce Greyson Homepage   Learn. Prepare. Survive. ► SUBSCRIBE/LISTEN: Spotify, iTunes, Stitcher, Google Play ► SUBSCRIBE/WATCH: Youtube TikTok ► CONTACT: Podcast@dadsdoomsdayguide.com / 213-465-3252 ► SOCIAL: TikTok: @dadsdoomsdayguide IG: @sco24, @timohara25

Tune into this podcast episode featuring a conversation between patient Brittany Clayborne – diagnosis: Peripartum Cardiomyopathy – and her physician Dr. Mark Drazner, HFSA President and Clinical Chief of Cardiology at University of Texas Southwestern Medical Center, Dallas, TX.

Tune into this podcast episode featuring a conversation between patient Brittany Clayborne – diagnosis: Peripartum Cardiomyopathy – and her physician Dr. Mark Drazner, HFSA President and Clinical Chief of Cardiology at University of Texas Southwestern Medical Center, Dallas, TX.

In this episode, Dr. Heung talks about his research focus in acute kidney injury (AKI), the effects of COVID-19 on the population of dialysis patients, and how we can keep our kidneys healthy. Dr. Heung is a nephrologist (kidney specialist) at the University of Michigan where he has practiced since 2005. While he is a general nephrologist and sees patients with a wide variety of kidney diseases, his particular research focus area is acute kidney injury. “So again, especially early in the pandemic, we saw very high rates of severe acute kidney injury in patients in the ICU with uh, COVID and in some studies, this was as high as 30, 35% of patients developing acute kidney injury, many of whom needed dialysis.” Question of the Day: What's something you want to do or have been doing to improve your kidney health? On This Episode You Will Learn: Acute Kidney Injury (AKI) Treatments and Prevention of AKI Covid 19 and Mortality Toll Dialysis Patients Maintaining Healthy Kidneys Connect with Yumlish! Website Instagram Twitter Facebook LinkedIn YouTube Connect with Micheal! Website Twitter Key Points: 00:00 - Intro with Shireen! 01:11 - Welcome, Dr. Heung. Can you talk a bit about how you gravitated toward your specialty in nephrology and your career journey to becoming Clinical Chief of Nephrology at the University of Michigan? 03:10 - Your main area of research is in Acute Kidney Injury (AKI). What is the definition of AKI and what are the risk factors for this condition? 05:20 - What are the current available treatments and what is the direction of research toward new and better treatments or prevention? 10:28 - You were quoted in a recent ProPublica article about the effects of COVID-19 on dialysis patients, discussing the unprecedented mortality toll on dialysis patients. What are some of the reasons for this population's unique vulnerabilities? 13:30 - What are your thoughts on the interaction between AKI and COVID-19? 15:26 - What do you do to keep your kidneys healthy? 20: 15 - How can our listeners connect with you and learn more about your work? 21:24 - Outro with Shireen! --- Send in a voice message: https://anchor.fm/yumlish/message

Seemingly amusing jargon like 'gyno', 'bitch tits', 'man boobs', and 'moobs' are just some of the slang used for the term gynecomastia. For those living with the emotional pain of having gynecomastia, there is little to be amused about. Despite that, it's exceedingly common and in most cases improvable. The blow to a man self confidence can be devastating. On today's episode, Dr. Peter Grossman has a candic conversation about gynecomastia with Dr. Andrew Cohen, board certified plastic surgeon specializing in gynecomastia procedures. He is a past, two-time Clinical Chief of the Division of Plastic Surgery at Cedars Sinai Medical Center in Los Angeles. His private practice is located in Encino, California. Learn More About the Host of Beauty and the BS Dr. Peter Grossman Follow Dr. Grossman on Instagram @dr.petergrossman  

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Salma Jabbour, Clinical Chief of Radiation Oncology at Rutgers Cancer Institute. Together they discuss radiation oncology and its role in cancer care. For more information, please visit: www.CarisLifeSciences.com

I am joined today by Dr Bruce  Greyson, to discuss the phenomenon of the Near-Death-Experience, and what this may tell us about consciousness.Dr. Bruce Greyson is the Chester Carlson Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia.  He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry. Dr. Greyson has consulted with the National Institutes of Health and addressed symposia on consciousness at the United Nations and at the Dalai Lama's compound in Dharamsala, India. He has earned awards for his medical research and was elected a Distinguished Life Fellow of the American Psychiatric Association, the highest honor bestowed by that organization.Dr. Greyson's interest in near-death experiences began just a few months after graduating from medical school, when he treated an unconscious patient in the emergency room who stunned him the next morning with an account of leaving her body. That event challenged his beliefs about the mind and the brain, and ultimately led him on a journey to study near-death experiences scientifically, leading to more than a hundred publications in medical journals. He co-founded the International Association for Near-Death Studies (IANDS), an organization to support and promote research into these experiences, and for 27 years edited the Journal of Near-Death Studies, the only scholarly journal dedicated to near-death research. Through his research, he has discovered common and universal themes in near-death experiences that go beyond neurophysiological or cultural interpretations, as well as patterns of consistent aftereffects on individuals' attitudes, beliefs, values, and personalities.Dr. Greyson is the author of After: A Doctor Explores What Near-Death Experiences Reveal About Life and Beyond. The book challenges our everyday ideas about our minds and our brains and offers key insights on how we can begin to live a more meaningful and fulfilling life.www.arabellathais.comhttps://www.brucegreyson.com

#181 My amazing guest today is Dr Bruce Greyson. Bruce is a retired psychiatrist who has spent years researching near death experiences and gathering personal accounts from 1000 people, all culminating in his most recent book, After. During our conversation, Bruce and I discuss near death experiences (NDE) in depth and talk about what it entails, whether it relates to religion or not, how common it actually is, and how people can, or cannot, adjust to “normal life” afterwards. If you've ever been interested in knowing more about what happens after we die, or if you have ever experienced an NDE yourself, this is the episode for you. “Now I'm quite comfortable with the idea that we're not going to have all the answers, that the unknown is not necessarily our enemy. They're just things that we can't formulate the right questions for.” About Bruce:  Dr. Bruce Greyson is the Chester Carlson Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia.  He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry. Dr. Greyson has consulted with the National Institutes of Health and addressed symposia on consciousness at the United Nations and at the Dalai Lama's compound in Dharamsala, India. Dr. Greyson's interest in near-death experiences began just a few months after graduating from medical school, when he treated an unconscious patient in the emergency room who stunned him the next morning with an account of leaving her body. That event challenged his beliefs about the mind and the brain, and ultimately led him on a journey to study near-death experiences scientifically, leading to more than a hundred publications in medical journals. He co-founded the International Association for Near-Death Studies (IANDS), an organization to support and promote research into these experiences, and for 27 years edited the Journal of Near-Death Studies, the only scholarly journal dedicated to near-death research. Through his research, he has discovered common and universal themes in near-death experiences that go beyond neurophysiological or cultural interpretations, as well as patterns of consistent aftereffects on individuals' attitudes, beliefs, values, and personalities. Bruce's Website: www.brucegreyson.com Bruce's Book:www.brucegreyson.com/after-a-doctor-explores-what-near-death-experiences-reveal-about-life-and-beyond Key points with time stamp: Near-Death Experiences & The Research Behind Them (00:00) A retired psychiatrist with a Near Death Experience (00:13) Public reception of an NDE (01:29) What makes an NDE worth studying? (03:00) Is an NDE a rare occurrence? (07:46) What holds us back from studying or discussing an NDE? (08:24) Was Bruce embarrassed of talking about his experience, as a doctor? (09:26) What qualifies as an NDE? (10:37) After an NDE (11:43) How can you safely experience a spiritual state like that of an NDE? (16:00) For the sceptic: Can spiritual experiences be measured? (18:04) Difference between Western an Eastern approaches to the world (19:54) The most unusual near-death experiences (22:27) The interplay between consciousness and religion (27:38) The experiences of Dr Eben Alexander (30:56) Staying open to conversations about NDE (33:01) How does being open to the unknown affect one's life? (34:39) Unpleasant NDE: What we don't hear about (35:51) Bruce's personal experience with the unknown (37:55) After: Reception and hopes for the book (38:44) Bouncing back from low points (40:08) Science as a source of spirituality (42:08) You are not abnormal, the situation is (43:39) Mentioned in this episode: Paul Aurand Dharamsala, India Dr Eben Alexander Anita Moorjani Albert Einstein Joseph Campbell Dalai Lama Desmond Tutu Carl Sagan After: A Doctor Explores What Near Death Experiences Reveal About Life and Beyond, 2021. Bruce's latest book. About me: My Instagram: www.instagram.com/guyhlawrence/?hl=en My website: www.guylawrence.com.au www.liveinflow.co

RFA Doctor Directory: www.rfamd.com During this video, the following topics are discussed: ✅ Finding treatments that are not over-aggressive and less-invasive. ✅ 70% of women and 50% of men have thyroid nodules ✅ Less than 10% of nodules are cancerous  ✅ Is radiofrequency ablation (RFA) an effective treatment? ✅ Is radiofrequency ablation (RFA) painful? ✅ How long does radiofrequency ablation (RFA) take to show results or shrinkage of the nodule? ✅ Ultrasound can categorize a nodule by low risk, intermediate, or high risk. ✅ Thyroidectomy comes with risks, including: vocal cord paralysis, bleeding, parathyroid damage, and nerve damage. ✅ Patients must educate themselves before seeing a doctor.   ✅ About Dr. Larian Babak Larian is a highly experienced, board certified Ear, Nose, & Throat Specialist and Head & Neck surgeon. Dr. Larian is the current Clinical Chief of the Division of Otolaryngology at Cedars-Sinai Hospital in Los Angeles (January 2012 – present).  He graduated with academic and humanitarian distinction, from UC Irvine School of Medicine. In 2002 after completing a 6-year residency program in Ear, Nose, & Throat (otolaryngology) and Head & Neck Surgery at UCLA, he began his professional career. He then went on to become a founding member and later the Medical Director of the Cedars-Sinai Head & Neck Center of Excellence (November 2009 – October 2011). CONTACT Email: info@larianmd.com Phone: 310.461.0300 Website: https://https://www.parotidsurgerymd.... Facebook: https://www.facebook.com/parotidsurge... Instagram: https://www.instagram.com/babaklarianmd/ ✅ About Philip James He is the host of the popular podcast: Doctor Thyroid www.docthyroid.com In 2013, his laryngeal nerve was severed, shoulder nerve damaged, parathyroids ruined, and residual cancer left behind — all for a 1 cm thyroid nodule. Later, a vocal cord implant was inserted to help him speak. All the above, the result of a bad thyroid surgery that dampened his quality of life — and left him wondering, what exactly happened — during what should be a low-risk surgery? His attempts to follow up with UCLA and the UCLA surgeon were ignored. He then turned to other doctors for answers — this was the beginning of the podcast: "Doctor Thyroid with Philip James" 100+ episodes later, the Doctor Thyroid podcast is popular amongst patients; allowing them to access information from top doctors, without being limited by geography or economics. The word he uses to describe his work as patient advocate is, ‘tonglen'. Or, using his pain and hardship to help others. When not producing podcast episodes or co-hosting live Q&As for patients with top doctors, he leads the creative team at Doctor Marketing and Philip James Media — a marketing agency dedicated to digital communications serving the sectors of healthcare, payments, and Greentech. The Doctor Thyroid podcast is available in Spanish and English - and listened to in over 30 countries: www.doctiroides.com (Spanish) www.docthyroid.com (English) ✅Please email your requests to philip@philipjames.co LinkedIn: www.linkedin.com/in/philip-james/ Facebook @docthyroid YouTube @Doctor Thyroid Twitter @docthyroid   Looking for a RFA doctor? Search the RFA Directory: www.rfamd.com

In this podcast, a panel consisting of Dr. Barry Chaiken, the Clinical Chief at Tableau Software, Charles Gabrial, the Project Manager of Standards & Interoperability at The Federal Electronic Health Record Modernization, Cupid Chan the BI & AI Committee Chair of LF Data & AI at the Linux Foundation, and Chris Cooper, the AVP of Health and Education at Collibra highlight the value of data intelligence within the healthcare industry.

Learn about the guest, Dr. Bruce Greyson:On his website: https://www.brucegreyson.com/Buy his book: https://us.macmillan.com/books/9781250792259UVA Division of Perceptual Studies: https://med.virginia.edu/perceptual-studies/Dr. Bruce Greyson is the Chester Carlson Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia. He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry. Dr. Greyson has consulted with the National Institutes of Health and addressed symposia on consciousness at the United Nations and at the Dalai Lama’s compound in Dharamsala, India. He has earned awards for his medical research and was elected a Distinguished Life Fellow of the American Psychiatric Association, the highest honor bestowed by that organization.Follow Whittney Evans and Cora Kessler of the Open Sesame Podcast on:Instagram at https://www.instagram.com/opensesamedia/Facebook Group at https://www.facebook.com/groups/OpenSesameListen on BuzzSprout at https://opensesame.buzzsprout.com/ or wherever you listen to your podcastsProperty of Open Sesame 2021

Bruce Greyson, M.D., is the Chester F. Carlson Professor Emeritus of Psychiatry & Neurobehavioral Sciences and Director Emeritus of the Division of Perceptual Studies at the University of Virginia. He was one of the founders of the International Association for Near-Death Studies, and for 27 years edited the Journal of Near-Death Studies. Dr. Greyson majored in psychology at Cornell University, received his medical degree from the SUNY Upstate Medical College, and completed his psychiatric residency at the University of Virginia. He practiced and taught psychiatry at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry, before returning to the University of Virginia 25 years ago. Dr. Greyson’s research for the past four decades has focused on the aftereffects and implications of near-death experiences. He is co-editor of The Near-Death Experience: Problems, Prospects, Perspectives, co-author of Irreducible Mind: Toward a Psychology for the 21st Century, and author of After: A Doctor Explores What Near-Death Experiences Reveal about Life and Beyond. Website: brucegreyson.com Discussion of this interview in the BatGap Community Facebook Group. Interview recorded February 26, 2021 Video and audio below. Audio also available as a Podcast.

 Dr. Bruce Greyson is the Chester Carlson Professor Emeritus of Psychiatry and Neurobehavioral Sciences at the University of Virginia (UVA), the Former Director of UVA's Division of Perceptual Studies, and has been widely acknowledged the father of research in the area of near-death experiences (NDE). He was previously on the medical faculty at the University of Michigan and the University of Connecticut, where he was Clinical Chief of Psychiatry. Dr. Greyson has consulted with the National Institutes of Health (NIH) and has addressed symposia on NDE, and the broader theme of consciousness, at wide range of venues from the United Nations, to an audience with the Dalai Lama. He has earned awards for his medical research and was elected a Distinguished Life Fellow of the American Psychiatric Association, the highest honor bestowed by that organization. Dr. Greyson's interest in near-death experiences began just a few months after graduating from medical school, with a fascinating case of an unconscious patient in the emergency room who stunned him the next morning with an account of leaving her body. That event challenged his beliefs about the mind and the brain, and ultimately led him on a journey to study near-death experiences scientifically, leading to more than a hundred publications in medical journals. Dr. Greyson co-founded the International Association for Near-Death Studies (IANDS), an organization to support and promote research into these experiences, and for 27 years edited the Journal of Near-Death Studies, the only scholarly journal dedicated to near-death research. Through his research, he has discovered common and universal themes in near-death experiences that go beyond neurophysiological or cultural interpretations, as well as patterns of consistent aftereffects on individuals' attitudes, beliefs, values, and personalities. Dr. Greyson is the author of "After: A Doctor Explores What Near-Death Experiences Reveal About Life and Beyond", as well as co-author of "Irreducible Mind", and co-editor of "The Handbook of Near-Death Experiences". 

This week I am talking to Dr Bruce Greyson about his book 'After: A Skeptical Scientist's Journey to Understand Life, Death, and Beyond'. In After: A Doctor Explores What Near-Death Experiences Reveal About Life and Beyond, one of the world's leading experts on near-death experiences shares the lessons he has learned over nearly a half century of studying near-death experiences. Backed by decades of pioneering scientific research and captivating first-hand accounts, Dr. Greyson reveals the evidence that led him to rethink his understanding of the nature of life, death, and the continuity of consciousness. Although NDEs reveal a lot about dying and what might come after, they reveal as much about life and living, about the value of compassion and our interconnectedness with one another, and about what makes a life meaningful and fulfilling. After invites us to open our minds to these experiences, and in so doing, expand our understanding of what it means to be human. Bruce Greyson is the Chester F. Carlson Professor of Psychiatry and Neurobehavioral Sciences and Director of the Division of Perceptual Studies at the University of Virginia Medical School. He graduated from Cornell University with a major in psychology in 1968, received his medical degree from the State University of New York Upstate Medical College in 1973, and subsequently completed his psychiatric residency at the University of Virginia. He held faculty appointments and taught psychiatry at the University of Michigan (1978-1984) and the University of Connecticut (1984-1995), where he was Clinical Chief of Psychiatry, before returning to the University of Virginia, where he has continued to teach and practice psychiatry and carry out research since 1995. One of the founding members of the International Association for Near-Death Studies, Dr. Greyson served on its Board of Directors and as its President and Director of Research. For the past 26 years, he has edited the Journal of Near-Death Studies, and was the senior editor of The Near-Death Experience: Problems, Prospects, Perspectives (Charles C Thomas, 1984), co-author of Irreducible Mind: Toward a Psychology for the 21st Century (Rowman & Littlefield, 2007), and co-editor of the forthcoming The Handbook of Near-Death Experiences: Thirty Years of Investigation (Praeger, 2009). His near-death research for the past three decades has focused on the aftereffects of the experience, and have resulted in more than 75 presentations to national and international scientific conferences, 100 publications in academic medical and psychological journals, and several research grants and awards. https://www.amazon.com/After-Doctor-Explores-Near-Death-Experiences-ebook/dp/B08BYDT3KL/ref=tmm_kin_swatch_0?_encoding=UTF8&qid=1613293764&sr=8-1 https://www.brucegreyson.com/ https://teespring.com/en-GB/stores/the-past-lives-podcast https://www.patreon.com/pastlivespodcast

Dr. Natalie Bridger EH Clinical Chief Of Infection Prevention & Control - Vaccine Roll Out by VOCM

Dr. Sean Connors Eastern Health Clinical Chief Of Cardiac Care - Backlog Of Cardiac Surgeries by VOCM

This episode shares our Fireside Chat with Dr. Uzma Shah on Women Leaders In Academic Medicine. Dr. Shah is an Associate Professor in Pediatrics, Harvard Medical School; Clinical Chief, Pediatric Gastroenterology and Nutrition, Director, Center for Pediatric Hepatobiliary and Pancreatic Disease; Director, Pediatric Liver Transplant Program, Massachusetts General Hospital

Guest Name and Bio: Leo Treyzon, MD, MS Leo Treyzon, MD, MS is an attending physician and previous Clinical Chief of the Division of Gastroenterology at Cedars-Sinai Medical Center. He is a board certified specialist in clinical nutrition and gastroentero

As a healthcare community charged with caring for people with compromised immune systems, a virus like COVID-19 raises a number of concerns for patients and staff alike. Dr. Jan Nowak, Clinical Chief of Molecular Pathology, wants to shed some light on how patients and employees are tested for the novel coronavirus at Roswell Park, how the test used here was selected, how quickly results are obtained and how patients and healthcare workers are being kept safe while waiting for the results.

A week after Jag Singh had tested positive for COVID-19, he became a patient in his hospital’s intensive care unit. This week he joins Ankur Kalra, MD to tell us about his journey as a clinician-scientist. Jagmeet P Singh, a Professor of Medicine at Harvard Medical School, a renowned Clinical Trialist, and the past Clinical Chief of Cardiology at Massachusetts General Hospital joins Ankur Kalra for a deep conversation about his journey across three continents. Dr Singh talks about the importance of choosing fulfillment over success. We gain more insights on the recent late-breaking clinical trial, MADIT-CHIC focusing on cardiac resynchronization therapy. Ankur asks Jag about his experience of being on the other side of the healthcare system as a patient and his participation in an investigational drug study. What is Dr Singh’s advice for young cardiologists? How does he balance his responsibilities? How did his hospitalisation shape Dr Singh’s outlook on his role as a medical professional? Tune in to listen to this week’s episode of Parallax. Hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO. Submit your questions to Ankur via: podcast@radciffe-group.com. In this episode they discuss: [02.09] Becoming a clinician-scientist [06.41] Boston and Massachusetts General Hospital [08:58] Creating balance and finding fulfilment as a cardiologist [19.05] The MADIT-CHIC trial [27.02] Experiencing COVID-19 as a patient [35:38] The emotional impact of COVID-19 [36:58] Investigational medications for the treatment of COVID-19 [39.55] Closing remarks Additional Resources: https://jamanetwork.com/journals/jama/article-abstract/2754793 https://twitter.com/NoopurRajeMD/status/1246905651491717122

In this episode of Critical Matters, we will discuss the latest evidence, the proper management and potential pitfalls of acute severe hypertension. Our guest is Dr. Aldo Peixoto. Dr. Peixoto is Professor of Medicine in the Section of Nephrology at the Yale University School of Medicine. He is also Vice Chair for Quality & Safety (Department of Internal Medicine) and Clinical Chief of the Section of Nephrology. Additional Links: Most recent US guidelines for the diagnosis and treatment of hypertension: http://bit.ly/39XlOFJ European position paper on management of hypertensive emergency: http://bit.ly/35G8eTT Severe Hypertension: http://bit.ly/2shwldW Books Mentioned in this Episode: Blindness by Jose Saramago: https://amzn.to/30863ak Portuguese Irregular Verbs by Alexander McCall Smith: https://amzn.to/35ARai4

Dr. Ramon Rami Porta, Clinical Chief of the Department of Thoracic Surgery at Hospital Universitari Mútua Terrassa, in Terrassa (Barcelona), Spain, joins Dr. Jack West for a discussion on the importance of lung cancer tumor staging, the status of CT Screening for lung cancer prevention in Europe and a preview of the IASLC World Conference on Lung Cancer in Barcelona. Listen to the end to get some tips on Barcelona culture, food and a great tip for waking up in the morning after a late dinner!

Heart disease remains the leading cause of death for both men and women in the United States. Dr. Charles Davidson, Clinical Chief of Cardiology at Northwestern Medicine Bluhm Cardiovascular Institute, has information about non-surgical treatments for coronary valve disease.

Heart disease remains the leading cause of death for both men and women in the United States. Dr. Charles Davidson, Clinical Chief of Cardiology at Northwestern Medicine Bluhm Cardiovascular Institute, has information about non-surgical treatments for coronary valve disease.

“Sleep affects everybody; we sleep for one third of our lives, it's the one activity we do the most of, and it's the one thing that if we don't do well or long enough, will have significant repercussions on our health, on our quality of life, and on others,” says Dr. Quan, Clinical Chief and Medical Director of the Division of Sleep and Circadian Disorders at Brigham Women's Hospital. With over half of the American population reporting that they don't get enough sleep, he argues that sleep deficiency has become an epidemic. While many people dismiss the importance of sleep, studies have shown that regularly getting fewer than six hours of sleep per night increases your risk of heart disease, stroke, high blood pressure, and diabetes, while lowering your overall quality of life and putting other people's lives in danger. Dr. Quan and his team are working to combat this problem with the Sleep Matters Initiative, which involves giving presentations about sleep health at various institutions and organizations, as well as administering screening questionnaires to all audience members after each presentation. If someone's answers on the questionnaire suggest that they might have a sleep issue, then the Sleep Matters Initiative will help them contact the right healthcare provider in order to have their sleep further evaluated.   Tune in to learn more from Dr. Quan, visit www.brighamandwomens.org to find the clinic and make an appointment, and learn more at www.understanidngsleep.org.

February is Heart Health Month. Cardiology can play a role in the treatment of cancer. Listen in as Edward Spangenthal, MD discusses his role as Clinical Chief of Cardiology at Roswell Park Comprehensive Cancer Center and the role of heart health in the field of cancer.

February is Heart Health Month. Cardiology can play a role in the treatment of cancer. Listen in as Edward Spangenthal, MD discusses his role as Clinical Chief of Cardiology at Roswell Park Comprehensive Cancer Center and the role of heart health in the field of cancer.

Palliative care is specialized medical care for people with serious illness. This type of care is focused on providing relief from the symptoms and stress of a serious illness. The goal is to improve quality of life for both the patient and the family.Amy Case, MD, the Clinical Chief of the Supportive and Palliative Care Program at Roswell Park Comprehensive Cancer Center, discusses the role of palliative medicine in cancer care.

Palliative care is specialized medical care for people with serious illness. This type of care is focused on providing relief from the symptoms and stress of a serious illness. The goal is to improve quality of life for both the patient and the family.Amy Case, MD, the Clinical Chief of the Supportive and Palliative Care Program at Roswell Park Comprehensive Cancer Center, discusses the role of palliative medicine in cancer care.

Dr. Babak Larian is a highly experienced, board certified Ear, Nose, & Throat Specialist and Head & Neck surgeon. Dr. Larian is the current Clinical Chief of the Division of Otolaryngology at Cedars-Sinai Hospital in Los Angeles.  Dr. Larian's Center For Head and Neck Surgery is located in Beverly Hills, California. In this episode, Dr. Larian discusses his experience treating thyroid disorders, including his medical missions to Central America.  During this interview, you will hear greater detail about the following topics: The most recent American Thyroid Association’s guidelines and updates to treating thyroid cancer compared to past approaches Minimally invasive thyroid surgery, which results in less scarring and less discomfort Breaking away from the old tradition of a large incision  Testing for parathyroid imbalance What might it mean when the patient feels anxious, has to urinate during the night, impaired mental function, and calcium imbalance?  Which blood test reveals possible parathyroid issues? The common denominator in patients who recover post thyroid cancer surgery A parathyroid trend in women 40 - 60 years old The importance of staying in tune with your body and its signals NOTES: Dr. Babak Larian http://www.larianmd.com/ P: 310.461.0300 American Thyroid Association Guidelines http://www.thyroid.org/professionals/ata-professional-guidelines/

Join hosts Wendy Poling and Tara Howes for an all NEW show! Featuring Guests: Sofia Vergara joins us to share her personal story of overcoming thyroid cancer and shares what you need to know for detecting an underactive thyroid. We also welcome Sofia's personal physician, Dr. Jordan Geller to the conversation. Dr. Geller is the Clinical Chief of the Division of Endocrinology, Diabetes, and Metabolism at the Cedars-Sinai Medical Center in Los Angeles. Sofia Vergara is the star of ABC's "Modern Family" and has two new movies coming out!   For more information visit: www.followthescriptcampaign.com Sofia Vergara IMDB --- (encore) Military Appreciation Night with USAA's Carl C. Liebert III, the President of USAA Capital Corporation. We chat in the players tunnel during a San Antonio Spurs basketball game! #emp Related link: USAA Salute Night Series Plus, we check out what's in the Mail Drop and answer your questions! There is always a hot topic or two we cover in Fireside Chat, so pour that favorite tea or coffee and join us for some candid conversation! Join us!